CPSC2020-03-18
NumbSkin Pain Relief Cream Recalled by SeeNext Venture Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning (Recall Alert)
SeeNext Venture Ltd., of Blaine, Wash.
Hazard
The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving cream contains lidocaine, posing a risk of poisoning to young children if they put it on their skin or ingest it.
Remedy
Consumers should immediately store the pain relief cream in a safe location out of reach of children and contact SeeNext Venture for instructions on how to dispose or return it and to receive a free replacement similar product with a child-resistant cap. Amazon is contacting all known purchasers directly.
Sold at
Online at Amazon.com from October 2019 through February 2020 for about $25.
Affected count
About 8,000
Injuries reported
None reported.
Manufactured in
Canada
Remedy type
Replace
Products
NumbSkin pain relief cream with lidocaine
Consumer contact
SeeNext Venture toll-free at 844-700-6862 from 9 a.m. to 6 p.m. PT Monday through Saturday, email at distributions@numbskin.com or online at www.numbskin.com and click on Recall at the home page for more information.
Official notice
https://www.cpsc.gov/Recalls/2020/NumbSkin-Pain-Relief-Cream-Recalled-by-SeeNext-Venture-Due-to-Failure-to-Meet-Child-Resistant-Packaging-Requirement-Risk-of-Poisoning-Recall-AlertDon't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief